Table of Content

1 Report Overview
1.1 Livestock Vaccines Definition
1.2 Market by Type
1.2.1 Global Livestock Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Foot and Mouth Disease Vaccine
1.2.3 Pig Ring Vaccine
1.2.4 Bird Flu Vaccine
1.2.5 Porcine Blue Ear Vaccine
1.2.6 Swine Fever Vaccine
1.3 Market Segment by Application
1.3.1 Global Livestock Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pig
1.3.3 Cattle and Sheep
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Livestock Vaccines Sales
2.1 Global Livestock Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Livestock Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Livestock Vaccines Revenue by Region
2.3.1 Global Livestock Vaccines Revenue by Region (2018-2024)
2.3.2 Global Livestock Vaccines Revenue by Region (2024-2034)
2.4 Global Livestock Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Livestock Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Livestock Vaccines Sales Quantity by Region
2.6.1 Global Livestock Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Livestock Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Livestock Vaccines Sales Quantity by Manufacturers
3.1.1 Global Livestock Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Livestock Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Livestock Vaccines Sales in 2022
3.2 Global Livestock Vaccines Revenue by Manufacturers
3.2.1 Global Livestock Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Livestock Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Livestock Vaccines Revenue in 2022
3.3 Global Livestock Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Livestock Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Livestock Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Livestock Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Livestock Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Livestock Vaccines Sales Quantity by Type
4.1.1 Global Livestock Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Livestock Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Livestock Vaccines Revenue by Type
4.2.1 Global Livestock Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Livestock Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Livestock Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Livestock Vaccines Price by Type
4.3.1 Global Livestock Vaccines Price by Type (2018-2024)
4.3.2 Global Livestock Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Livestock Vaccines Sales Quantity by Application
5.1.1 Global Livestock Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Livestock Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Livestock Vaccines Revenue by Application
5.2.1 Global Livestock Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Livestock Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Livestock Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Livestock Vaccines Price by Application
5.3.1 Global Livestock Vaccines Price by Application (2018-2024)
5.3.2 Global Livestock Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Livestock Vaccines Sales by Company
6.1.1 North America Livestock Vaccines Revenue by Company (2018-2024)
6.1.2 North America Livestock Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Livestock Vaccines Market Size by Type
6.2.1 North America Livestock Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Livestock Vaccines Revenue by Type (2018-2034)
6.3 North America Livestock Vaccines Market Size by Application
6.3.1 North America Livestock Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Livestock Vaccines Revenue by Application (2018-2034)
6.4 North America Livestock Vaccines Market Size by Country
6.4.1 North America Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Livestock Vaccines Revenue by Country (2018-2034)
6.4.3 North America Livestock Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Livestock Vaccines Sales by Company
7.1.1 Europe Livestock Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Livestock Vaccines Revenue by Company (2018-2024)
7.2 Europe Livestock Vaccines Market Size by Type
7.2.1 Europe Livestock Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Livestock Vaccines Revenue by Type (2018-2034)
7.3 Europe Livestock Vaccines Market Size by Application
7.3.1 Europe Livestock Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Livestock Vaccines Revenue by Application (2018-2034)
7.4 Europe Livestock Vaccines Market Size by Country
7.4.1 Europe Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Livestock Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Livestock Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Livestock Vaccines Sales by Company
8.1.1 China Livestock Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Livestock Vaccines Revenue by Company (2018-2024)
8.2 China Livestock Vaccines Market Size by Type
8.2.1 China Livestock Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Livestock Vaccines Revenue by Type (2018-2034)
8.3 China Livestock Vaccines Market Size by Application
8.3.1 China Livestock Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Livestock Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Livestock Vaccines Sales by Company
9.1.1 APAC Livestock Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Livestock Vaccines Revenue by Company (2018-2024)
9.2 APAC Livestock Vaccines Market Size by Type
9.2.1 APAC Livestock Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Livestock Vaccines Revenue by Type (2018-2034)
9.3 APAC Livestock Vaccines Market Size by Application
9.3.1 APAC Livestock Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Livestock Vaccines Revenue by Application (2018-2034)
9.4 APAC Livestock Vaccines Market Size by Region
9.4.1 APAC Livestock Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Livestock Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Livestock Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Livestock Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Livestock Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Livestock Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Livestock Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Livestock Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Livestock Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Livestock Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Livestock Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Livestock Vaccines Products and Services
11.1.5 Merck Livestock Vaccines SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Livestock Vaccines Products and Services
11.2.5 Boehringer Ingelheim Livestock Vaccines SWOT Analysis
11.2.6 Boehringer Ingelheim Recent Developments
11.3 Ceva
11.3.1 Ceva Company Information
11.3.2 Ceva Overview
11.3.3 Ceva Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Ceva Livestock Vaccines Products and Services
11.3.5 Ceva Livestock Vaccines SWOT Analysis
11.3.6 Ceva Recent Developments
11.4 Zoetis
11.4.1 Zoetis Company Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Zoetis Livestock Vaccines Products and Services
11.4.5 Zoetis Livestock Vaccines SWOT Analysis
11.4.6 Zoetis Recent Developments
11.5 Vaxxinova®
11.5.1 Vaxxinova® Company Information
11.5.2 Vaxxinova® Overview
11.5.3 Vaxxinova® Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Vaxxinova® Livestock Vaccines Products and Services
11.5.5 Vaxxinova® Livestock Vaccines SWOT Analysis
11.5.6 Vaxxinova® Recent Developments
11.6 Elanco
11.6.1 Elanco Company Information
11.6.2 Elanco Overview
11.6.3 Elanco Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Elanco Livestock Vaccines Products and Services
11.6.5 Elanco Livestock Vaccines SWOT Analysis
11.6.6 Elanco Recent Developments
11.7 QYH Biotech Co., Ltd
11.7.1 QYH Biotech Co., Ltd Company Information
11.7.2 QYH Biotech Co., Ltd Overview
11.7.3 QYH Biotech Co., Ltd Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 QYH Biotech Co., Ltd Livestock Vaccines Products and Services
11.7.5 QYH Biotech Co., Ltd Livestock Vaccines SWOT Analysis
11.7.6 QYH Biotech Co., Ltd Recent Developments
11.8 Pulike
11.8.1 Pulike Company Information
11.8.2 Pulike Overview
11.8.3 Pulike Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Pulike Livestock Vaccines Products and Services
11.8.5 Pulike Livestock Vaccines SWOT Analysis
11.8.6 Pulike Recent Developments
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Company Information
11.9.2 Phibro Animal Health Corporation Overview
11.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Phibro Animal Health Corporation Livestock Vaccines Products and Services
11.9.5 Phibro Animal Health Corporation Livestock Vaccines SWOT Analysis
11.9.6 Phibro Animal Health Corporation Recent Developments
11.10 JinYu Biotechnology
11.10.1 JinYu Biotechnology Company Information
11.10.2 JinYu Biotechnology Overview
11.10.3 JinYu Biotechnology Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 JinYu Biotechnology Livestock Vaccines Products and Services
11.10.5 JinYu Biotechnology Livestock Vaccines SWOT Analysis
11.10.6 JinYu Biotechnology Recent Developments
11.11 Harbin Pharmaceutical Group
11.11.1 Harbin Pharmaceutical Group Company Information
11.11.2 Harbin Pharmaceutical Group Overview
11.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Harbin Pharmaceutical Group Livestock Vaccines Products and Services
11.11.5 Harbin Pharmaceutical Group Recent Developments
11.12 MEVAC
11.12.1 MEVAC Company Information
11.12.2 MEVAC Overview
11.12.3 MEVAC Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 MEVAC Livestock Vaccines Products and Services
11.12.5 MEVAC Recent Developments
11.13 Venky's
11.13.1 Venky's Company Information
11.13.2 Venky's Overview
11.13.3 Venky's Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Venky's Livestock Vaccines Products and Services
11.13.5 Venky's Recent Developments
11.14 Japfa Comfeed Indonesia
11.14.1 Japfa Comfeed Indonesia Company Information
11.14.2 Japfa Comfeed Indonesia Overview
11.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Japfa Comfeed Indonesia Livestock Vaccines Products and Services
11.14.5 Japfa Comfeed Indonesia Recent Developments
11.15 Nisseiken
11.15.1 Nisseiken Company Information
11.15.2 Nisseiken Overview
11.15.3 Nisseiken Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Nisseiken Livestock Vaccines Products and Services
11.15.5 Nisseiken Recent Developments
11.16 Hile
11.16.1 Hile Company Information
11.16.2 Hile Overview
11.16.3 Hile Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Hile Livestock Vaccines Products and Services
11.16.5 Hile Recent Developments
11.17 Hester Biosciences
11.17.1 Hester Biosciences Company Information
11.17.2 Hester Biosciences Overview
11.17.3 Hester Biosciences Livestock Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Hester Biosciences Livestock Vaccines Products and Services
11.17.5 Hester Biosciences Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Livestock Vaccines Value Chain Analysis
12.2 Livestock Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Livestock Vaccines Production Mode & Process
12.4 Livestock Vaccines Sales and Marketing
12.4.1 Livestock Vaccines Sales Channels
12.4.2 Livestock Vaccines Distributors
12.5 Livestock Vaccines Customers
13 Market Dynamics
13.1 Livestock Vaccines Industry Trends
13.2 Livestock Vaccines Market Drivers
13.3 Livestock Vaccines Market Challenges
13.4 Livestock Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Livestock Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Foot and Mouth Disease Vaccine
Table 3. Major Manufacturers of Pig Ring Vaccine
Table 4. Major Manufacturers of Bird Flu Vaccine
Table 5. Major Manufacturers of Porcine Blue Ear Vaccine
Table 6. Major Manufacturers of Swine Fever Vaccine
Table 7. Global Livestock Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Livestock Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Livestock Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Livestock Vaccines Revenue Market Share by Region (2018-2024)
Table 11. Global Livestock Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Livestock Vaccines Revenue Market Share by Region (2024-2034)
Table 13. Global Livestock Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 14. Global Livestock Vaccines Sales by Region (2018-2024) & (K Units)
Table 15. Global Livestock Vaccines Sales Market Share by Region (2018-2024)
Table 16. Global Livestock Vaccines Sales by Region (2024-2034) & (K Units)
Table 17. Global Livestock Vaccines Sales Market Share by Region (2024-2034)
Table 18. Global Livestock Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 19. Global Livestock Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Livestock Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Livestock Vaccines Revenue Share by Manufacturers (2018-2024)
Table 22. Global Livestock Vaccines Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Key Players of Livestock Vaccines, Industry Ranking, 2021 VS 2022
Table 24. Global Livestock Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Livestock Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Livestock Vaccines as of 2022)
Table 26. Global Key Manufacturers of Livestock Vaccines, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Livestock Vaccines, Product Offered and Application
Table 28. Global Key Manufacturers of Livestock Vaccines, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 31. Global Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 32. Global Livestock Vaccines Sales Quantity Share by Type (2018-2024)
Table 33. Global Livestock Vaccines Sales Quantity Share by Type (2024-2034)
Table 34. Global Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Livestock Vaccines Revenue Share by Type (2018-2024)
Table 37. Global Livestock Vaccines Revenue Share by Type (2024-2034)
Table 38. Livestock Vaccines Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Livestock Vaccines Price Forecast by Type (2024-2034) & (US$/Unit)
Table 40. Global Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 41. Global Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 42. Global Livestock Vaccines Sales Quantity Share by Application (2018-2024)
Table 43. Global Livestock Vaccines Sales Quantity Share by Application (2024-2034)
Table 44. Global Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Livestock Vaccines Revenue Share by Application (2018-2024)
Table 47. Global Livestock Vaccines Revenue Share by Application (2024-2034)
Table 48. Livestock Vaccines Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Livestock Vaccines Price Forecast by Application (2024-2034) & (US$/Unit)
Table 50. North America Livestock Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Livestock Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 52. North America Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 53. North America Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 54. North America Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 57. North America Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 58. North America Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Livestock Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Livestock Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Livestock Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 64. North America Livestock Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 65. Europe Livestock Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 66. Europe Livestock Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 68. Europe Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 69. Europe Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 72. Europe Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 73. Europe Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Livestock Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Livestock Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Livestock Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 79. Europe Livestock Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 80. China Livestock Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 81. China Livestock Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 83. China Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 84. China Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 87. China Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 88. China Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Livestock Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 91. APAC Livestock Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 93. APAC Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 94. APAC Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 97. APAC Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 98. APAC Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Livestock Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Livestock Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Livestock Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Livestock Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 104. APAC Livestock Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Livestock Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 109. Middle East, Africa and Latin America Livestock Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Livestock Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 112. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 113. Middle East, Africa and Latin America Livestock Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Livestock Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Livestock Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Livestock Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Livestock Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 119. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 120. Merck Company Information
Table 121. Merck Description and Overview
Table 122. Merck Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 123. Merck Livestock Vaccines Product and Services
Table 124. Merck Livestock Vaccines SWOT Analysis
Table 125. Merck Recent Developments
Table 126. Boehringer Ingelheim Company Information
Table 127. Boehringer Ingelheim Description and Overview
Table 128. Boehringer Ingelheim Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 129. Boehringer Ingelheim Livestock Vaccines Product and Services
Table 130. Boehringer Ingelheim Livestock Vaccines SWOT Analysis
Table 131. Boehringer Ingelheim Recent Developments
Table 132. Ceva Company Information
Table 133. Ceva Description and Overview
Table 134. Ceva Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 135. Ceva Livestock Vaccines Product and Services
Table 136. Ceva Livestock Vaccines SWOT Analysis
Table 137. Ceva Recent Developments
Table 138. Zoetis Company Information
Table 139. Zoetis Description and Overview
Table 140. Zoetis Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 141. Zoetis Livestock Vaccines Product and Services
Table 142. Zoetis Livestock Vaccines SWOT Analysis
Table 143. Zoetis Recent Developments
Table 144. Vaxxinova® Company Information
Table 145. Vaxxinova® Description and Overview
Table 146. Vaxxinova® Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 147. Vaxxinova® Livestock Vaccines Product and Services
Table 148. Vaxxinova® Livestock Vaccines SWOT Analysis
Table 149. Vaxxinova® Recent Developments
Table 150. Elanco Company Information
Table 151. Elanco Description and Overview
Table 152. Elanco Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 153. Elanco Livestock Vaccines Product and Services
Table 154. Elanco Livestock Vaccines SWOT Analysis
Table 155. Elanco Recent Developments
Table 156. QYH Biotech Co., Ltd Company Information
Table 157. QYH Biotech Co., Ltd Description and Overview
Table 158. QYH Biotech Co., Ltd Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 159. QYH Biotech Co., Ltd Livestock Vaccines Product and Services
Table 160. QYH Biotech Co., Ltd Livestock Vaccines SWOT Analysis
Table 161. QYH Biotech Co., Ltd Recent Developments
Table 162. Pulike Company Information
Table 163. Pulike Description and Overview
Table 164. Pulike Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 165. Pulike Livestock Vaccines Product and Services
Table 166. Pulike Livestock Vaccines SWOT Analysis
Table 167. Pulike Recent Developments
Table 168. Phibro Animal Health Corporation Company Information
Table 169. Phibro Animal Health Corporation Description and Overview
Table 170. Phibro Animal Health Corporation Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 171. Phibro Animal Health Corporation Livestock Vaccines Product and Services
Table 172. Phibro Animal Health Corporation Livestock Vaccines SWOT Analysis
Table 173. Phibro Animal Health Corporation Recent Developments
Table 174. JinYu Biotechnology Company Information
Table 175. JinYu Biotechnology Description and Overview
Table 176. JinYu Biotechnology Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 177. JinYu Biotechnology Livestock Vaccines Product and Services
Table 178. JinYu Biotechnology Livestock Vaccines SWOT Analysis
Table 179. JinYu Biotechnology Recent Developments
Table 180. Harbin Pharmaceutical Group Company Information
Table 181. Harbin Pharmaceutical Group Description and Overview
Table 182. Harbin Pharmaceutical Group Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 183. Harbin Pharmaceutical Group Livestock Vaccines Product and Services
Table 184. Harbin Pharmaceutical Group Recent Developments
Table 185. MEVAC Company Information
Table 186. MEVAC Description and Overview
Table 187. MEVAC Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 188. MEVAC Livestock Vaccines Product and Services
Table 189. MEVAC Recent Developments
Table 190. Venky's Company Information
Table 191. Venky's Description and Overview
Table 192. Venky's Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 193. Venky's Livestock Vaccines Product and Services
Table 194. Venky's Recent Developments
Table 195. Japfa Comfeed Indonesia Company Information
Table 196. Japfa Comfeed Indonesia Description and Overview
Table 197. Japfa Comfeed Indonesia Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 198. Japfa Comfeed Indonesia Livestock Vaccines Product and Services
Table 199. Japfa Comfeed Indonesia Recent Developments
Table 200. Nisseiken Company Information
Table 201. Nisseiken Description and Overview
Table 202. Nisseiken Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 203. Nisseiken Livestock Vaccines Product and Services
Table 204. Nisseiken Recent Developments
Table 205. Hile Company Information
Table 206. Hile Description and Overview
Table 207. Hile Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 208. Hile Livestock Vaccines Product and Services
Table 209. Hile Recent Developments
Table 210. Hester Biosciences Company Information
Table 211. Hester Biosciences Description and Overview
Table 212. Hester Biosciences Livestock Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 213. Hester Biosciences Livestock Vaccines Product and Services
Table 214. Hester Biosciences Recent Developments
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Livestock Vaccines Distributors List
Table 218. Livestock Vaccines Customers List
Table 219. Livestock Vaccines Market Trends
Table 220. Livestock Vaccines Market Drivers
Table 221. Livestock Vaccines Market Challenges
Table 222. Livestock Vaccines Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Livestock Vaccines Product Picture
Figure 2. Global Livestock Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Livestock Vaccines Market Share by Type in 2022 & 2034
Figure 4. Foot and Mouth Disease Vaccine Product Picture
Figure 5. Pig Ring Vaccine Product Picture
Figure 6. Bird Flu Vaccine Product Picture
Figure 7. Porcine Blue Ear Vaccine Product Picture
Figure 8. Swine Fever Vaccine Product Picture
Figure 9. Global Livestock Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Livestock Vaccines Market Share by Application in 2022 & 2034
Figure 11. Pig
Figure 12. Cattle and Sheep
Figure 13. Others
Figure 14. Livestock Vaccines Report Years Considered
Figure 15. Global Livestock Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Livestock Vaccines Revenue 2018-2034 (US$ Million)
Figure 17. Global Livestock Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Livestock Vaccines Sales Quantity 2018-2034 (K Units)
Figure 19. Global Livestock Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Livestock Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Livestock Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. North America Livestock Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Livestock Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. Europe Livestock Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Livestock Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. China Livestock Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Livestock Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. APAC Livestock Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Livestock Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Livestock Vaccines Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Livestock Vaccines Revenue in 2022
Figure 33. Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 36. Global Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 38. North America Livestock Vaccines Revenue Market Share by Company in 2022
Figure 39. North America Livestock Vaccines Sales Quantity Market Share by Company in 2022
Figure 40. North America Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 42. North America Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 44. North America Livestock Vaccines Revenue Share by Country (2018-2034)
Figure 45. North America Livestock Vaccines Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Livestock Vaccines Sales Quantity Market Share by Company in 2022
Figure 49. Europe Livestock Vaccines Revenue Market Share by Company in 2022
Figure 50. Europe Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 52. Europe Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 54. Europe Livestock Vaccines Revenue Share by Country (2018-2034)
Figure 55. Europe Livestock Vaccines Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. France Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. China Livestock Vaccines Sales Quantity Market Share by Company in 2022
Figure 62. China Livestock Vaccines Revenue Market Share by Company in 2022
Figure 63. China Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 65. China Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 67. APAC Livestock Vaccines Sales Quantity Market Share by Company in 2022
Figure 68. APAC Livestock Vaccines Revenue Market Share by Company in 2022
Figure 69. APAC Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 71. APAC Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 73. APAC Livestock Vaccines Revenue Share by Region (2018-2034)
Figure 74. APAC Livestock Vaccines Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. India Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Livestock Vaccines Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Livestock Vaccines Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Livestock Vaccines Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Livestock Vaccines Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Livestock Vaccines Revenue Share by Country (2018-2034)
Figure 88. Brazil Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Livestock Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. Livestock Vaccines Value Chain
Figure 94. Livestock Vaccines Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed